M. Dcona

发表

CtBP- an emerging oncogene and novel small molecule drug target: Advances in the understanding of its oncogenic action and identification of therapeutic inhibitors

S. Grossman, Benjamin L. Morris, M. Dcona, 2017, Cancer biology & therapy.

Active-Site Tryptophan, the Target of Antineoplastic C-Terminal Binding Protein Inhibitors, Mediates Inhibitor Disruption of CtBP Oligomerization and Transcription Coregulatory Activities

S. Grossman, W. Royer, C. Escalante, 2019, Molecular Pharmacology.

Active-site tryptophan, the target of anti-neoplastic CtBP inhibitors, mediates inhibitor disruption of CtBP oligomerization and transcription coregulatory activities

W. Royer, Steven, C. Escalante, 2019 .

A new, highly water-soluble, fluorescent turn-on chemodosimeter for direct measurement of hydrogen sulfide in biological fluids.

M. Siluvai Michael, Matthew C. T. Hartman, M. Dcona, 2012, The Analyst.

Drug Delivery Strategies Using Light Sensitive Molecules

M. Dcona, 2012 .

CryoEM Structure of CtBP2 Confirms Tetrameric Architecture [preprint]

C. Schiffer, S. Grossman, W. Royer, 2021 .

Photocontrolled activation of small molecule cancer therapeutics.

Koushambi Mitra, Matthew C. T. Hartman, M. Dcona, 2020, RSC medicinal chemistry.

Photoswitchable anticancer activity via trans-cis isomerization of a combretastatin A-4 analog.

C. Lyons, Matthew C. T. Hartman, J. Hackett, 2016, Organic & biomolecular chemistry.

Cryo-EM Structure of CtBP2 Confirms Tetrameric Architecture.

C. Schiffer, S. Grossman, W. Royer, 2020, Structure.

CryoEM Structure of CtBP2 Confirms Tetrameric Architecture

C. Schiffer, S. Grossman, W. Royer, 2020, bioRxiv.

Kinases: The "Indispensables"of the DNA Damage Response Cascade

V. Menon, M. Dcona, 2019, JoLS, Journal of Life Sciences.

Photocaged permeability: a new strategy for controlled drug release.

D. Gewirtz, Matthew C. T. Hartman, D. Lebman, 2012, Chemical communications.